Skip to main content
. 2022 Apr 30;22:173. doi: 10.1186/s12890-022-01968-2

Table 2.

Predominant cell type infiltrating tumour stroma and number of patients in each group

Predominant cell type infiltrating tumour stroma Number (%) Survival days (IQR)
Lymphocytic 92 (78%) 368 (198–689)
Neutrophilic 10 (8%) 233 (74–375)
Equal 9 (8%) 204 (108–380)
Acellular 7 (6%) 258 (108–562)